Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax Inc (NQ: NVAX )

7.670 +0.580 (+8.18%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 29,181,253
Open 7.080
Bid (Size) 7.590 (6)
Ask (Size) 7.600 (15)
Prev. Close 7.090
Today's Range 6.730 - 8.150
52wk Range 5.605 - 25.66
Shares Outstanding 74,484,166
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Trump's SPAC Partner Digital World, Novavax, Palantir, And Tesla: Why These Stocks Are Trending Today?
U.S. stocks experienced a downturn, with significant losses noted toward the end of trading. The S&P 500 fell approximately 1.4%. 
Via Benzinga
Topics Government Stocks
Exposures Political US Equities
Novavax Surges After FDA Signs Off On Its Updated Covid Shot, Joining Pfizer, Moderna
The company can now join Pfizer and Moderna in launching an updated booster in the U.S. 
Via Investor's Business Daily
Exposures COVID-19 Product Safety

Performance

YTD
-21.65%
-21.65%
1 Month
-15.25%
-15.25%
3 Month
+4.21%
+4.21%
6 Month
+4.50%
+4.50%
1 Year
-58.76%
-58.76%

More News

Read More
Novavax Stock Soars On FDA Clearance For Updated Covid-19 Shot: What's Going On?
Via Benzinga
Exposures COVID-19 Product Safety
Why Pfizer and BioNTech Stocks Zoomed Higher Today
Via The Motley Fool
Exposures COVID-19
NVAX, AI, CVNA: The 3 Most Shorted Stocks This Month
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Up 20% in 1 Month, Is This Stock a Buy?
Via The Motley Fool
Exposures COVID-19
Ticking Time Bombs: 3 Biotech Stocks to Dump Before the Damage Is Done
Via InvestorPlace
Does This Message From Moderna Mean Bad News for Novavax?
Via The Motley Fool
You Can Pick Up These High-Risk, High-Reward Stocks for Less Than $10
Via The Motley Fool
Is This 250-Year-Old Japanese Big Pharma Giant Selling For Half Price Right Now?
Via Benzinga
More Than Half Of Americans Want New COVID-19 Booster, But Ron DeSantis Will Fight Virus With His Charisma Alone
Via Benzinga
Exposures COVID-19 Product Safety
Why COVID Vaccine Demand Might Not Be That Strong
Via The Motley Fool
Exposures COVID-19
Novavax Is a Step Behind, Again. Should You Be Worried?
Via The Motley Fool
Exposures Product Safety
DraftKings Apologizes For 9/11 'Never Forget' Parlay Promotion, Apple Set For Selling 'Made In India' iPhone 15 on Launch Day, MGM Resorts Faces Ongoing Cyber Incident: Today's Top Stories
Via Benzinga
Tesla, Oracle, Novavax, DraftKings, Pfizer: Why These Five Stocks Are Tending Today
Via Benzinga
Topics Stocks
Exposures US Equities
Moderna, Pfizer Get FDA Nod For Omicron COVID Boosters While Novavax Waits
Via Benzinga
Exposures COVID-19 Product Safety
Novavax Dives As Pfizer, Moderna Snag First Nods For Covid Boosters
Via Investor's Business Daily
Exposures COVID-19 Product Safety
7 Biotech Stocks to Sell in September Before They Crash & Burn
Via InvestorPlace
Non-Disappearing COVID Creates Another Chapter For The Pharmaceutical Industry
Via Benzinga
Exposures COVID-19
Here's How Moderna's Updated Covid Shot Stacks Up Against Highly Mutated 'Pirola' Variant
Via Investor's Business Daily
Exposures COVID-19
This Down-on-Its-Luck Biotech Could Surge 150%, Wall Street Says. Should You Buy the Stock?
Via The Motley Fool
Novavax, Zscaler, Digital Brands Group, Asana, Tesla: Why These 5 Stocks Are Drawing Investor Attention Today
Via Benzinga
Why Novavax Stock Rocketed 10% Higher Today
Via The Motley Fool
Exposures COVID-19
Why Novavax Stock Traded Higher Today
Via Benzinga
Exposures COVID-19
Coronavirus Cases Are on the Rise -- Should You Buy Vaccine Stocks?
Via The Motley Fool
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.